宣泰医药 (688247.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(宣泰医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 111,411,602.18299,871,288.42213,364,344.65110,765,423.7342,418,265.20247,562,432.66186,903,609.72127,853,233.2363,179,209.56
 营业利润(元) 26,588,025.9869,011,763.3047,892,033.3624,979,409.607,823,729.7899,131,640.4673,362,201.5845,225,908.7523,452,801.43
 利润总额(元) 26,403,628.9065,990,781.4847,883,803.7925,054,791.437,823,921.8397,475,420.6472,487,122.0644,349,224.8122,657,281.93
 净利润(元) 22,895,905.4861,074,068.0744,072,638.0322,778,585.587,716,721.4892,941,482.9667,102,611.3540,204,247.1020,263,118.79
 归属于母公司股东的净利润(元) 22,895,905.4861,074,068.0744,072,638.0322,778,585.587,716,721.4892,941,482.9667,102,611.3540,204,247.1020,263,118.79
盈利能力:
 销售毛利率(%) 45.4555.8950.6154.9656.2471.2373.5572.6277.64
 销售净利率(%) 20.5520.3720.6620.5618.1937.5435.9031.4532.07
 净资产收益率(%) 1.925.123.762.380.81----
 总资产报酬率ROA(%) 1.874.363.101.680.77----
 投入资本回报率ROIC(%) 1.905.123.721.920.659.877.235.542.83
营运能力:
 存货周转率(次) 1.052.322.330.970.51----
 应收账款周转率(次) 2.084.613.802.471.01----
 总资产周转率(次) 0.080.220.160.100.04----
偿债能力:
 资产负债率(%) 11.2711.1211.8113.0110.8311.6411.5918.5117.65
 股东权益比率(%) 88.7388.8888.1986.9989.1788.3688.4181.4982.35
 已获利息倍数(倍) -19.54-8.11-6.07-3.1413.18-10.47-8.59-8.51-60.63
 流动比率 9.9410.499.258.3011.7010.5911.295.726.77
 速动比率 8.799.358.307.4510.859.9310.775.246.14
发展能力:
 营业收入增长率(%) 162.6521.1314.16-13.37-32.86-21.53-19.15-18.133.47
 营业利润增长率(%) 239.84-30.38-34.72-44.77-66.64-18.285.64-4.2160.29
 税后利润增长率(%) 196.71-34.28-34.32-43.34-61.92-31.1110.028.8168.34
 净资产增长率(%) 1.342.803.7957.2263.3566.9582.1222.76-
 总资产增长率(%) 1.842.204.0547.2850.8453.8862.6316.49-

前瞻产业研究院